Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,169 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Montreal, Sherbrooke, East Syracuse NY, Hartford CT,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

for
Untreated Follicular Lymphoma
Location: Montreal, Saint-Jerôme, Quebec, Albany NY, Chicoutimi,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06549595

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Montreal, Quebec, New Haven CT, Barrie, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

for
Venous Thromboembolism
Location: Montreal, Ottawa, Windsor
Sponsor: Ottawa Hospital Research Institute

Sex: All

Age: 18+

Code: NCT06440694

Phase 3, Recruiting

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

for
Gastroesophageal Adenocarcinoma
Location: Montreal, Newark DE, Pittsburgh PA, Washington D.C. DC,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07069712

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Montreal, Greenfield Park, Saint-Hubert, Terrebonne,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)

for
PSC
Location: Montreal, Boston MA, New Haven CT, Toronto, Richmond VA,
Sponsor: PSC Partners Seeking a Cure

Sex: All

Age: 18 - 70+

Code: NCT06297993

Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Montreal, Trois-Rivieres, Levis, Chicoutimi, Boston MA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Montreal, Saint-Jerôme, Kingston, South Portland ME,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase 3, Recruiting

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

for
Locally Advanced Cervical Cancer
Location: Montreal, Toronto, Hamilton
Sponsor: AstraZeneca

Sex: Female

Age: 15+

Code: NCT06079671

Phase 3, Recruiting

Treatment of Brain AVMs (TOBAS) Study

for
Unruptured Brain Arteriovenous Malformation,
Location: Montreal, Boston MA, Jacksonville FL, Edmonton,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 5+

Code: NCT02098252

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Montreal, Greenfield Park, Trois-Rivieres,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Montreal, Greenfield Park, Quebec, Providence RI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

for
Viral Lung Infection and Acute Respiratory Failure
Location: Montreal, Ottawa, Quebec, Levis, Toronto, Brampton,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05624450

Phase 3, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Montreal, Laval, Burlington VT, Quebec, Albany NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Montreal, Lebanon NH, Quebec, Boston MA, Providence RI,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Using Micro-filaments to Detect "fast Ripples" and Improve the Identification of the Epileptogenic Zone

for
Epilepsy, Refractory
Location: Montreal
Sponsor: Adrien Peyrache

Sex: All

Age: 0+

Code: NCT05254730

Recruiting

Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)

for
Multiple Sclerosis
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18 - 65

Code: NCT02408380

Recruiting
New

Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)

for
Glaucoma, Corneal Transplantation, Inflammation
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04339907

Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Montreal, Hackensack NJ, Hamilton, Iowa City IA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase 1, Phase 2, Recruiting